A longtime Fred Hutch booster helps a promising genetic researcher parlay $100K into a $2.2M grant to explore innovative new therapies
Feb. 24, 2017
| By Diane Mapes and Rachel Tompa / Fred Hutch News Service
Funding for novel and unexpected findings isn’t always forthcoming, especially in a climate in which only the top 7 percent or so grants submitted to the National Institutes of Health are given a green light. This is a story of how a longtime Fred Hutch booster helped a promising cancer geneticist parlay $100K into a $2.2M grant.
$8.8 million NIH grant to help expand study of colorectal cancer outcomes; new Evergreen Fund to accelerate commercialization of research; Hutch United co-chair Erin dela Cruz receives fellowhip from American Society for Microbiology; Marlins pitcher Dustin McGowan named winner of 52nd Hutch Award